carcinoembryon
antigenrel
cell
adhes
molecul
singlepass
transmembran
type
glycoproteinand
protein
belong
immunoglobulin
ig
superfamili
wide
express
protein
affect
normal
pathogen
process
associ
cellular
growth
differenti
recent
studi
demonstr
serum
level
increas
patient
pancreat
adenocarcinoma
lung
cancer
melanoma
increas
correl
cancer
progress
provid
evid
potenti
valu
circul
tumor
marker
gastrointestin
cancer
accumul
immunohistochem
vitro
evid
indic
epitheli
express
associ
tumor
metastasi
progress
howev
littl
inform
avail
concern
serum
especi
gastrointestin
cancer
one
lead
caus
cancerrel
death
therefor
necessari
evalu
chang
serum
context
gastrointestin
cancer
human
exist
known
isoform
result
differenti
splice
proteolyt
process
isoform
differ
respect
number
extracellular
iglik
domain
membran
anchorag
length
cytoplasm
tail
two
major
kind
splice
isoform
ie
differ
cytoplasm
domain
isoform
long
cytoplasm
domain
contain
two
immunoreceptor
tyrosinebas
inhibitori
motif
itim
gener
transmit
inhibitori
signal
isoform
lack
itim
motif
contain
sequenc
bind
calmodulin
tropomyosin
globular
actin
transduc
stimul
signal
regul
interact
cytoskeleton
isoform
function
inhibitori
commonli
report
isoform
cell
type
tissu
express
togeth
characterist
differ
ratio
howev
littl
inform
avail
concern
isoform
express
pattern
cancer
inform
would
valuabl
demonstr
two
isoform
mutual
regul
activ
determin
whether
could
use
discrimin
cancer
patient
health
control
studi
compar
serum
level
gastrointestin
cancer
patient
benign
diseas
healthi
control
follow
recommend
obuchowski
et
al
exploratori
phase
phase
studi
distribut
primari
cancer
tissu
analyz
immunohistochem
stain
addit
express
pattern
isoform
verifi
revers
transcriptionpolymeras
chain
reaction
rtpcr
total
serum
sampl
incorpor
research
includ
sampl
obtain
upper
gastric
cancer
duoden
carcinoma
averag
age
year
rang
year
lower
colon
cancer
rectal
cancer
averag
age
year
rang
year
gastrointestin
cancer
patient
patient
diseas
outsid
gastrointestin
tract
exclud
patient
benign
gastrointestin
diseas
sampl
collect
sex
agematch
healthi
volunt
includ
control
inform
consent
collect
patient
particip
studi
conduct
approv
ethic
committe
scientif
ethic
committe
shanghai
jiao
tong
univers
accord
helsinki
declar
revis
patient
receiv
chemotherapi
radiat
therapi
sampl
collect
serum
collect
divid
aliquot
frozen
analysi
tissu
sampl
also
collect
parallel
cancer
patient
mention
surgeri
cancer
section
adjac
normal
mucosa
section
collect
follow
patholog
confirm
tissu
flash
frozen
liquid
nitrogen
serum
measur
commerci
enzymelink
immunosorb
assay
elisa
kit
raybiotech
atlanta
usa
accord
manufactur
instruct
previous
describ
antihuman
antibodi
recogn
extracellular
domain
aa
human
access
number
determin
express
local
immunohistochemistri
perform
paraffinembed
specimen
mous
monoclon
antibodi
clone
dilut
abcam
cambridg
uk
previous
describ
specif
antibodi
test
western
blot
analysi
supplementari
fig
briefli
section
dewax
endogen
peroxidas
block
incub
hydrogen
peroxid
solut
min
follow
antigen
retriev
wash
time
phosphatebuff
salin
pb
ph
min
section
incub
primari
antibodi
humid
chamber
overnight
thereaft
section
rins
pb
incub
biotinyl
secondari
antibodi
dako
glostrup
denmark
humidifi
chamber
min
wash
streptavidinperoxidas
complex
reagent
strepabcomplexhrp
duet
dako
glostrup
denmark
ad
incub
min
room
temperatur
final
section
incub
solut
min
immers
run
tap
water
counterstain
haematoxylin
min
rins
tap
water
immers
seri
alcohol
bath
increas
concentr
final
slide
cover
coverslip
examin
microscop
primari
antibodi
omit
neg
control
rtpcr
primer
f
r
report
wang
et
al
gaur
et
al
design
distinguish
isoform
simultan
gapdh
use
intern
control
sampl
f
r
pcr
perform
use
rt
reagent
kit
takara
bio
inc
shiga
japan
follow
manufactur
protocol
describ
previous
predenatur
min
main
oper
system
cycl
min
final
product
subject
agaros
gel
electrophoresi
result
express
median
rang
data
normal
distribut
test
employ
determin
signific
two
independ
group
variou
group
respect
nonparametr
receiv
oper
characterist
roc
curv
use
evalu
diagnost
accuraci
serum
level
repres
integr
optic
densiti
iod
valu
imag
pro
plu
window
media
cybernet
inc
rockvil
usa
briefli
intens
rectif
iod
obtain
ratio
sum
optic
densiti
od
sum
area
proport
quantiti
rna
statist
signific
set
p
report
p
valu
analys
perform
spss
window
spss
inc
chicago
usa
sigmaplot
v
window
systat
softwar
inc
san
jose
usa
clinic
patholog
characterist
patient
shown
tabl
median
serum
level
patient
cancer
benign
diseas
significantli
higher
healthi
control
p
fig
howev
signific
differ
level
found
cancer
patient
benign
diseas
p
fig
identifi
whether
serum
level
associ
clinic
patholog
paramet
test
perform
tabl
among
cancer
patient
serum
level
simpli
elev
tumor
progress
howev
level
increas
significantli
earli
advanc
diseas
stage
notabl
differ
reach
level
signific
cancer
patient
categor
tumor
extens
lymphat
invas
p
dramat
elev
earli
period
cancer
develop
highlight
potenti
use
serum
earli
tumor
screen
marker
multivari
logist
regress
analysi
level
could
use
predict
cancer
versu
healthi
control
adjust
age
gender
effect
accord
odd
ratio
valu
level
better
lower
gastrointestin
cancer
upper
gastrointestin
cancer
tabl
diagnost
valu
serum
also
analyz
nonparametr
roc
curv
serum
level
benign
diseas
patient
also
increas
surpris
diagnost
valu
distinguish
cancer
patient
healthi
control
better
distinguish
benign
diseas
patient
healthi
control
accord
auc
valu
ci
p
ci
p
respect
fig
b
auc
valu
serum
distinguish
lower
gastrointestin
cancer
patient
healthi
control
reach
ci
p
higher
ci
p
observ
upper
gastrointestin
cancer
group
fig
base
cutoff
valu
calcul
accord
youden
index
indic
diagnost
accuraci
summar
fig
use
serum
distinguish
lower
gastrointestin
cancer
patient
healthi
control
group
highest
indic
valu
includ
auc
sensit
posit
predict
valu
posit
likelihood
ratio
addit
rel
low
sensit
high
specif
indic
serum
may
better
use
combin
marker
notabl
chang
express
found
cancer
tissu
compar
adjac
normal
tissu
immunohistochem
studi
reveal
littl
express
normal
tissu
adjac
cancer
fig
c
howev
cancer
tissu
protein
detect
mostli
secret
form
within
neoplast
gland
fig
furthermor
cancer
tissu
express
intens
invas
front
lumin
surfac
case
fig
suggest
express
may
involv
tumor
invas
accord
previou
report
serum
data
show
associ
level
tumor
extens
tabl
determin
whether
express
pattern
alter
primari
gastrointestin
cancer
pair
primari
cancer
normal
tissu
sampl
upper
lower
analyz
use
pcr
primer
report
gaur
et
al
wang
et
al
figur
show
repres
rtpcr
data
forward
primer
locat
exon
revers
primer
locat
within
untransl
region
thu
primer
could
amplifi
bp
fragment
bp
fragment
simultan
base
inclus
exclus
exon
shown
tabl
l
ratio
significantli
higher
cancer
tissu
adjac
normal
tissu
p
radic
downregul
malign
tissu
mainli
respons
result
express
basic
unchang
tabl
find
demonstr
isoform
ratio
upregul
tumorigenesi
rais
possibl
role
gastrointestin
cancer
may
depend
isoform
domin
studi
first
aim
determin
whether
could
discrimin
gastrointestin
cancer
patient
healthi
control
protein
level
elisa
analysi
demonstr
serum
protein
level
associ
increas
risk
gastrointestin
cancer
fig
accord
previou
observ
express
breast
cancer
lung
cancer
prostat
cancer
addit
auc
roc
analysi
remark
exceed
fig
gastrointestin
cancer
compar
either
healthi
control
mix
particip
benign
diseas
healthi
group
latter
situat
accur
repres
clinic
practic
moreov
express
earli
stage
diseas
much
higher
advanc
stage
tabl
suggest
level
increas
earli
stage
thu
may
serv
screen
indictor
cancer
howev
note
easytodiagnos
patient
enrol
phase
studi
result
may
overestim
accuraci
marker
addit
design
sampl
size
accord
goal
determin
whether
serum
abil
discrimin
cancer
noncanc
patient
result
futur
larger
prospect
studi
need
valid
prognost
valu
serum
second
also
explor
sourc
biolog
function
solubl
accord
previou
studi
besid
natur
occur
differenti
splice
proteolyt
process
circul
produc
tumor
cell
endotheli
cell
secret
cleavag
membranebound
immunohistochem
result
fig
show
secret
form
within
cancer
tissu
consist
previou
report
furthermor
show
higher
intens
invas
front
cancer
tissu
fig
accord
previou
studi
addit
transform
lumin
surfac
invas
front
could
partli
explain
rel
decreas
serum
observ
patient
advanc
stage
cancer
tabl
huang
yh
colleagu
found
form
heterodimer
interact
ci
tran
serv
heterophil
ligand
inde
coblockad
lead
enhanc
antitumor
immun
respons
mous
colorect
cancer
model
circul
report
act
block
antibodi
modul
block
signal
transmit
membraneanchor
reason
specul
interact
immun
cell
may
explain
circul
involv
cancer
progress
suspect
similar
mechan
involv
gastrointestin
carcinoma
l
ratio
cancer
higher
adjac
normal
tissu
decreas
express
mainli
respons
phenomenon
tabl
fig
previou
studi
also
demonstr
isoform
may
possess
costimulatori
function
either
homophil
heterophil
interact
chang
dimer
monomer
state
therefor
isoform
capabl
modifi
inhibitori
signal
provid
express
togeth
equilibrium
l
ratio
studi
undoubtedli
affect
cellular
respons
downstream
signal
molecul
bind
srcfamili
kinas
togeth
result
indic
upregul
l
ratio
associ
tumorigenesi
gastrointestin
cancer
summari
data
demonstr
protein
level
upregul
serum
gastrointestin
cancer
patient
moreov
mrna
level
decreas
cancer
tissu
level
remain
gener
unchang
suggest
gener
express
level
link
oncogenesi
moreov
immunohistochemistri
result
show
alter
locat
express
along
tumor
develop
progress
indic
involv
tumor
invas
metastasi
result
consist
previou
report
although
exact
mechan
remain
elucid
detail
investig
provid
evid
complex
role
play
cancer
conclus
studi
strongli
suggest
potenti
use
serum
indic
cancer
diagnosi
howev
involv
cancer
complex
studi
requir
better
understand
mechan
underli
observ
help
develop
diagnost
therapeut
strategi
target
